Skuldtech is an innovative biotechnology company specialized in the discovery of genomic biomarkers.  The company comprises three departments: Services, Human healthcare and Animal healthcare.

Skuldtech is involved in several national and international research programs funded by the European Union and other funding partners. These programs are focused on the identification of biomarkers, the development of diagnosis tools and innovative therapeutics.

The objective of the company is to construct a biomarker and product portfolio as well as technological intellectual property pipeline. Validated biomarkers will either be out-licensed or used in-house for final products.